{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:21:28Z","timestamp":1782930088796,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-07682-1","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:29:55Z","timestamp":1748597395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study protocol. TRAAPREVIA\u2014TRAnexamic acid for preventing blood loss following a cesarean delivery in women with a placenta pREVIA or low-lying placenta: a multicenter randomized, double blind, placebo controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Lo\u00efc","family":"Sentilhes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Madar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Ifrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Deneux-Tharaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the TRAAPREVIA Study Group, the Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie (GROG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"7682_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/01.AOG.0000207559.15715.98","volume":"107","author":"Y Oyelese","year":"2006","unstructured":"Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107:927\u201341.","journal-title":"Obstet Gynecol"},{"key":"7682_CR2","doi-asserted-by":"crossref","unstructured":"Reddy UM, Abuhamad AZ, Levine D, Saade GR; Fetal Imaging Workshop Invited Participants. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal- Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging workshop. J Ultrasound Med 2014;33:745\u201357.","DOI":"10.7863\/ultra.33.5.745"},{"key":"7682_CR3","doi-asserted-by":"crossref","unstructured":"Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al; Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019 Jan;126(1):e1-e48.","DOI":"10.1111\/1471-0528.15306"},{"key":"7682_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejogrb.2015.12.012","volume":"198","author":"L Sentilhes","year":"2016","unstructured":"Sentilhes L, Vayssi\u00e8re C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet MP, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12\u201321.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7682_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/AOG.0000000000001005","volume":"126","author":"RM Silver","year":"2015","unstructured":"Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126:654\u201368.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"7682_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/AOG.0000000000004890","volume":"140","author":"A Froeliger","year":"2022","unstructured":"Froeliger A, Madar H, Jeanneteau P, Ruiz V, Le Lous M, Perrotin F, et al. Trial of Labor Compared With Elective Cesarean Delivery for Low-Lying Placenta. Obstet Gynecol. 2022;140(3):429\u201338.","journal-title":"Obstet Gynecol"},{"key":"7682_CR7","doi-asserted-by":"crossref","unstructured":"Jain V, Bos H, Bujold E. Guideline No. 402: diagnosis and management of placenta previa. J Obstet Gynaecol Can 2020;42:906\u201317.","DOI":"10.1016\/j.jogc.2019.07.019"},{"key":"7682_CR8","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/tmi.12100","volume":"18","author":"JA Cresswell","year":"2013","unstructured":"Cresswell JA, Ronsmans C, Calvert C, Filippi V. Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Trop Med Int Health. 2013;18:712\u201324.","journal-title":"Trop Med Int Health"},{"key":"7682_CR9","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0002-9378(11)90776-5","volume":"168","author":"S Iyasu","year":"1993","unstructured":"Iyasu S, Saftlas AK, Rowley DL, Koonin LM, Lawson HW, Atrash HK. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol. 1993;168:1424\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"7682_CR10","doi-asserted-by":"crossref","unstructured":"Grobman WA, Gersnoviez R, Landon MB, Spong CY, Leveno KJ, Rouse DJ, et al; National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007;110:1249\u201355.","DOI":"10.1097\/01.AOG.0000292082.80566.cd"},{"key":"7682_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0029-7844(96)00236-0","volume":"88","author":"CV Ananth","year":"1996","unstructured":"Ananth CV, Wilcox AJ, Savitz DA, Bowes WA Jr, Luther ER. Effect of maternal age and parity on the risk of uteroplacental bleeding disorders in pregnancy. Obstet Gynecol. 1996;88:511\u20136.","journal-title":"Obstet Gynecol"},{"key":"7682_CR12","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3109\/14767058.2011.553695","volume":"24","author":"KN Solheim","year":"2011","unstructured":"Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24:1341\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"669","key":"7682_CR13","first-page":"e1","volume":"212","author":"KL Downes","year":"2015","unstructured":"Downes KL, Hinkle SN, Sjaarda LA, Albert PS, Grantz KL. Previous prelabor or intrapartum cesarean delivery and risk of placenta previa. Am J Obstet Gynecol. 2015;212(669):e1-6.","journal-title":"Am J Obstet Gynecol"},{"key":"7682_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/14767058.2017.1289163","volume":"31","author":"KJ Gibbins","year":"2018","unstructured":"Gibbins KJ, Einerson BD, Varner MW, Silver RM. Placenta previa and maternal hemorrhagic morbidity. J Matern Fetal Neonatal Med. 2018;31:494\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"7682_CR15","doi-asserted-by":"crossref","unstructured":"Crane JM, Van den Hof MC, Dodds L, Armson BA, Liston R. Maternal complications with placenta previa. Am J Perinatol 2000;17:101\u20135.Sd.","DOI":"10.1055\/s-2000-9269"},{"key":"7682_CR16","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0002-9378(99)70031-1","volume":"180","author":"MC Frederiksen","year":"1999","unstructured":"Frederiksen MC, Glassenberg R, Stika CS. Placenta previa: a 22-year analysis. Am J Obstet Gynecol. 1999;180:1432\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7682_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/01.AOG.0000236547.35234.8c","volume":"108","author":"DJ Rouse","year":"2006","unstructured":"Rouse DJ, MacPherson C, Landon M, Varner MW, Leveno KJ, Moawad AH, et al. Blood transfusion and cesarean delivery. Obstet Gynecol. 2006;108(4):891\u20137.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"7682_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/17474086.2019.1642744","volume":"12","author":"L Sentilhes","year":"2019","unstructured":"Sentilhes L, Madar H, Mattuizzi A, Froeliger A, Merlot B, Elleboode B, et al. Tranexamic acid for childbirth: why, when, and for whom. Expert Rev Hematol. 2019;12(9):753\u201361.","journal-title":"Expert Rev Hematol"},{"key":"7682_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3054","volume":"344","author":"K Ker","year":"2012","unstructured":"Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344: e3054.","journal-title":"BMJ"},{"key":"7682_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1606424","volume":"376","author":"PS Myles","year":"2017","unstructured":"Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136\u201348.","journal-title":"N Engl J Med"},{"key":"7682_CR21","doi-asserted-by":"crossref","unstructured":"The CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23\u201332.","DOI":"10.1016\/S0140-6736(10)60835-5"},{"key":"7682_CR22","doi-asserted-by":"crossref","unstructured":"The CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019; 394:1713\u201323.","DOI":"10.1016\/S0140-6736(19)32233-0"},{"key":"7682_CR23","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","unstructured":"WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebocontrolled trial. Lancet. 2017;389:2105\u201316.","journal-title":"Lancet"},{"key":"7682_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","volume":"391","author":"A Gayet-Ageron","year":"2018","unstructured":"Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a metaanalysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018;391:125\u201332.","journal-title":"Lancet"},{"key":"7682_CR25","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Winer N, Azria E, S\u00e9nat MV, Le Ray C, Vardon D, et al; Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery. N Engl J Med 2018;379:731\u2013742.","DOI":"10.1056\/NEJMoa1800942"},{"key":"7682_CR26","doi-asserted-by":"crossref","unstructured":"Sentilhes L, S\u00e9nat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, et al; Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery. N Engl J Med 2021;384:1623\u20131634.","DOI":"10.1056\/NEJMoa2028788"},{"key":"7682_CR27","unstructured":"Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal\u2013Fetal Medicine Units Network. Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery. N Engl J Med. 2023 Apr 13;388(15):1365\u20131375."},{"key":"7682_CR28","doi-asserted-by":"crossref","unstructured":"Durand-Zaleski I, Deneux-Tharaux C, Seco A, Malki M, Frenkiel J, Sentilhes L; for TRAAP study group. An economic evaluation of tranexamic acid to prevent postpartum haemorrhage in women with vaginal delivery: the randomised controlled TRAAP trial. BJOG. 2021 Jan;128:114\u2013120.","DOI":"10.1111\/1471-0528.16456"},{"key":"7682_CR29","doi-asserted-by":"crossref","unstructured":"Sentilhes L, B\u00e9nard A, Madar H, Froeliger A, Petit S, Deneux-Tharaux C; TRAAP2 study group. Tranexamic acid for reduction of blood loss after Caesarean delivery: a cost-effectiveness analysis of the TRAAP2 trial. Br J Anaesth. 2023 Nov;131:893\u2013900.","DOI":"10.1016\/j.bja.2023.07.028"},{"key":"7682_CR30","doi-asserted-by":"publisher","unstructured":"WOMAN-2 Trial Collaborators. The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2024;404(10463):1645\u20131656. https:\/\/doi.org\/10.1016\/S0140-6736(24)01749-5","DOI":"10.1016\/S0140-6736(24)01749-5"},{"key":"7682_CR31","doi-asserted-by":"crossref","unstructured":"Ker K, Sentilhes L, Shakur-Still H, Madar H, Deneux-Tharaux C, Saade G, Pacheco LD, Ageron FX, Mansukhani R, Balogun E, Brenner A, Prowse D, Arribas M, Ahmadzia H, Chaudhri R, Olayemi O, Roberts I; Anti-fibrinolytics Trialists Collaborators Obstetric Group. Tranexamic acid for postpartum bleeding: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet. 2024 Oct 26;404(10463):1657\u20131667.","DOI":"10.1016\/S0140-6736(24)02102-0"},{"issue":"10463","key":"7682_CR32","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/S0140-6736(24)02302-X","volume":"404","author":"BWJ Mol","year":"2024","unstructured":"Mol BWJ, Flanagan M, Li W. Prevention and treatment of postpartum haemorrhage: progress by learning what works and what does not work. Lancet. 2024;404(10463):1616\u20138.","journal-title":"Lancet"},{"key":"7682_CR33","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1055\/s-0042-1755379","volume":"122","author":"S Roullet","year":"2022","unstructured":"Roullet S, Rivoire T, Houssin C, Labrouche S, Paquin S, Nouette-Gaulain K, Deneux-Tharaux C, Amiral J, James C, Sentilhes L. Hemostatic Effects of Tranexamic Acid in Cesarean Delivery: An Ancillary Study of the TRAAP2 Study. Thromb Haemost. 2022;122:1869\u201378.","journal-title":"Thromb Haemost"},{"key":"7682_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2021.103206","volume":"48","author":"A Shander","year":"2021","unstructured":"Shander A, Javidroozi M, Sentilhes L. Tranexamic acid and obstetric hemorrhage: give empirically or selectively? Int J Obstet Anesth. 2021;48: 103206.","journal-title":"Int J Obstet Anesth"},{"key":"7682_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ajog.2021.12.039","volume":"226","author":"L Sentilhes","year":"2022","unstructured":"Sentilhes L, Deneux-Tharaux C, Roberts I, Ker K. Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery. Am J Obstet Gynecol. 2022;226:755\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"7682_CR36","unstructured":"Sentilhes L, Madar H, Le Lous M, S\u00e9nat MV, Winer N, Rozenberg P, et al; Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie. Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary analysis of the TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery randomized clinical trial. Am J Obstet Gynecol. 2022 Dec;227(6):889.e1\u2013889.e17."},{"key":"7682_CR37","doi-asserted-by":"publisher","first-page":"13535","DOI":"10.1038\/s41598-019-49566-3","volume":"9","author":"C Wang","year":"2019","unstructured":"Wang C, Le Ray I, Lee B, Wikman A, Reilly M. Association of blood group and red blood cell transfusion with the incidence of antepartum, peripartum and postpartum venous thromboembolism. Sci Rep. 2019;9:13535.","journal-title":"Sci Rep"},{"key":"7682_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/s-0039-1697664","volume":"120","author":"SY Lin","year":"2020","unstructured":"Lin SY, Chang YL, Yeh HC, Lin CL, Kao CH. Blood transfusion and risk of venous thromboembolism: a population-based cohort study. Thromb Haemost. 2020;120:156\u201367.","journal-title":"Thromb Haemost"},{"key":"7682_CR39","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jamasurg.2018.1565","volume":"153","author":"R Goel","year":"2018","unstructured":"Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, et al. Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry. JAMA Surg. 2018;153:826\u201333.","journal-title":"JAMA Surg"},{"key":"7682_CR40","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Daniel V, Darsonval A, Deruelle P, Vardon D, Perrotin F, et al. Study protocol. TRAAP \u2013 TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. BMC Pregnancy Childbirth 20015;15:135.","DOI":"10.1186\/s12884-015-0573-5"},{"key":"7682_CR41","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Daniel V, Deneux-Tharaux C; TRAAP2 Study Group and the Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie (GROG). TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol. BMC Pregnancy Childbirth. 2020 Jan 31;20:63.","DOI":"10.1186\/s12884-019-2718-4"},{"key":"7682_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0301-2115(03)00287-2","volume":"112","author":"M Gai","year":"2004","unstructured":"Gai M, Wu L, Su Q, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol. 2004;112:154\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7682_CR43","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/AOG.0000000000003564","volume":"134","author":"Quantitative Blood Loss in Obstetric Hemorrhage","year":"2019","unstructured":"Quantitative Blood Loss in Obstetric Hemorrhage. ACOG Committee Opinion, Number 794. Obstet Gynecol. 2019;134:e150\u20136.","journal-title":"Obstet Gynecol"},{"key":"7682_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4661","volume":"343","author":"SR Sheehan","year":"2011","unstructured":"Sheehan SR, Montgomery AA, Carey M, McAuliffe FM, Eogan M, Gleeson R, et al. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. 2011;343: d4661. https:\/\/doi.org\/10.1136\/bmj.d4661.","journal-title":"BMJ"},{"key":"7682_CR45","doi-asserted-by":"crossref","unstructured":"Madar H, Deneux-Tharaux C, Sentilhes L; TRAAP Study Group. Shock index as a predictor of postpartum haemorrhage after vaginal delivery: Secondary analysis of a multicentre randomised controlled trial. BJOG. 2024 Feb;131(3):343\u2013352.","DOI":"10.1111\/1471-0528.17634"},{"key":"7682_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15335","author":"S Meher","year":"2018","unstructured":"Meher S, Cuthbert A, Kirkham JJ, Williamson P, Abalos E, Aflaifel N, et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG. 2018. https:\/\/doi.org\/10.1111\/1471-0528.15335.","journal-title":"BJOG"},{"key":"7682_CR47","doi-asserted-by":"crossref","unstructured":"Froeliger A, Deneux-Tharaux C, Seco A, Sentilhes L; TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery (TRAAP) Study Group. Posttraumatic Stress Disorder Symptoms 2 Months After Vaginal Delivery. Obstet Gynecol 2022;139:63\u201372.","DOI":"10.1097\/AOG.0000000000004611"},{"key":"7682_CR48","unstructured":"Froeliger A, Deneux-Tharaux C, Loussert L, Madar H, Sentilhes L; Tranexamic Acid for Preventing Postpartum Hemorrhage after Cesarean Delivery (TRAAP2) trial study group. Posttraumatic stress disorder 2 months after cesarean delivery: a multicenter prospective study. Am J Obstet Gynecol 2024:S0002\u20139378(24)00440-X."},{"key":"7682_CR49","doi-asserted-by":"crossref","unstructured":"Froeliger A, Deneux-Tharaux C, Loussert L, Bouchghoul H, Madar H, Sentilhes L; TRanexamic Acid for Preventing Postpartum Hemorrhage After Vaginal Delivery Study Group. Prevalence and risk factors for postpartum depression 2 months after a vaginal delivery: a prospective multicenter study. Am J Obstet Gynecol 2024;230(3S):S1128-S1137.6.","DOI":"10.1016\/j.ajog.2023.08.026"},{"key":"7682_CR50","unstructured":"Froeliger A, Deneux-Tharaux C, Loussert L, Bouchghoul H, Laure Sutter-Dallay A, Madar H, Sentilhes L; TRAAP2 study group. Prevalence and risk factors for postpartum depression 2 months after cesarean delivery: a prospective multicenter study. Am J Obstet Gynecol. 2024 Oct 30:S0002\u20139378(24)01103\u20137."},{"key":"7682_CR51","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ajog.2009.03.018","volume":"201","author":"JG Hofmeyr","year":"2009","unstructured":"Hofmeyr JG, Novikova N, Mathai M, Shah A. Techniques for cesarean section. Am J Obstet Gynecol. 2009;201:431\u201344.","journal-title":"Am J Obstet Gynecol"},{"key":"7682_CR52","doi-asserted-by":"crossref","unstructured":"Hofmeyr GJ, Mathai M, Shah A, Novikova N. Techniques for caesarean section. Cochrane Database Syst Rev 2008:CD004662","DOI":"10.1002\/14651858.CD004662.pub2"},{"key":"7682_CR53","doi-asserted-by":"crossref","unstructured":"Anorlu RI, Maholwana B, Hofmeyr GJ. Methods of delivering the placenta at caesarean section. Cochrane Database Syst Rev 2008;:CD004737.","DOI":"10.1002\/14651858.CD004737.pub2"},{"key":"7682_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijgo.2014.07.020","volume":"128","author":"E Verspyck","year":"2015","unstructured":"Verspyck E, Douysset X, Roman H, Marret S, Marpeau L. Transecting versus avoiding incision of the anterior placenta previa during cesarean delivery. Int J Gynaecol Obstet. 2015;128:44\u20137.","journal-title":"Int J Gynaecol Obstet"},{"key":"7682_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.101065","volume":"5","author":"H Madar","year":"2023","unstructured":"Madar H, Sentilhes L, Goffinet F, Bonnet MP, Rozenberg P, Deneux-Tharaux C. Comparison of quantitative and calculated postpartum blood loss after vaginal delivery. Am J Obstet Gynecol MFM. 2023;5: 101065.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"519","key":"7682_CR56","first-page":"e1","volume":"199","author":"I Stafford","year":"2008","unstructured":"Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199(519):e1-7.","journal-title":"Am J Obstet Gynecol"},{"key":"7682_CR57","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/17474086.2016.1245135","volume":"9","author":"L Sentilhes","year":"2016","unstructured":"Sentilhes L, Merlot B, Madar H, Brun S, Sztark F, Deneux-Tharaux C. Postpartum haemorrhage: prevention and treatment. Expert Rev Hematol. 2016;9:1043\u201361.","journal-title":"Expert Rev Hematol"},{"key":"7682_CR58","doi-asserted-by":"crossref","unstructured":"Sentilhes L, Goffinet F, Vayssi\u00e8re C, Deneux-Tharaux. Comparison of postpartum haemorrhage guidelines: discrepancies underline our ignorance. BJOG 2017;124:718\u2013722.","DOI":"10.1111\/1471-0528.14305"},{"key":"7682_CR59","doi-asserted-by":"crossref","unstructured":"Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-e186.","DOI":"10.1097\/AOG.0000000000002351"},{"key":"7682_CR60","unstructured":"Recommendations WHO for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization, 2012."},{"key":"7682_CR61","doi-asserted-by":"crossref","unstructured":"Saucedo M, Deneux-Tharaux C, Bouvier-Colle M-H, French National Experts Committee on Maternal Mortality. Ten years of confidential inquiries into maternal deaths in France, 1998\u20132007. Obstet Gynecol 2013;122:752\u201360.","DOI":"10.1097\/AOG.0b013e31829fc38c"},{"key":"7682_CR62","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1471-0528.2010.02648.x","volume":"117","author":"C Deneux-Tharaux","year":"2010","unstructured":"Deneux-Tharaux C, Dupont C, Colin C, et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG Int J Obstet Gynaecol. 2010;117:1278\u201387.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"346","key":"7682_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1541","volume":"28","author":"C Deneux-Tharaux","year":"2013","unstructured":"Deneux-Tharaux C, Sentilhes L, Maillard F, Closset E, Vardon D, Lepercq J, Goffinet F. Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR). BMJ. 2013;28(346): f1541.","journal-title":"BMJ"},{"key":"7682_CR64","doi-asserted-by":"crossref","unstructured":"Boulvain M, Senat MV, Perrotin F, Winer N, Beucher G, Subtil D, et al; Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie (GROG). Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet 2015;385(9987):2600\u20135.","DOI":"10.1016\/S0140-6736(14)61904-8"},{"key":"7682_CR65","doi-asserted-by":"crossref","unstructured":"Malan V, Bussi\u00e8res L, Winer N, Jais JP, Baptiste A, Le Lorc'h M, et al; SAFE 21 Study Group. Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial. JAMA 2018;320:557\u2013565.","DOI":"10.1001\/jama.2018.9396"},{"key":"7682_CR66","doi-asserted-by":"crossref","unstructured":"S\u00e9nat MV, Affres H, Letourneau A, Coustols-Valat M, Cazaubiel M, Legardeur H, et al; Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie (GROG). Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial. JAMA 2018;319:1773\u20131780.","DOI":"10.1001\/jama.2018.4072"},{"key":"7682_CR67","doi-asserted-by":"crossref","unstructured":"Schmitz T, Doret-Dion M, Sentilhes L, Parant O, Claris O, Renesme L, et al; BETADOSE trial study group; Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie. Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. Lancet 2022;400(10352):592\u2013604.","DOI":"10.1016\/S0140-6736(22)01535-5"},{"key":"7682_CR68","doi-asserted-by":"crossref","unstructured":"Girault A, Sentilhes L, Desbri\u00e8re R, Berveiller P, Korb D, Bertholdt C, et al; collaborators of the STOPOXY trial and the Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie (GROG). Impact of discontinuing oxytocin in active labour on neonatal morbidity: an open-label, multicentre, randomised trial. Lancet 2023;402:2091\u20132100.","DOI":"10.1016\/S0140-6736(23)01803-2"},{"key":"7682_CR69","doi-asserted-by":"crossref","unstructured":"Kayem G, Deneux-Tharaux C, Sentilhes L; PACCRETA group. PACCRETA: clinical situations at high risk of placenta ACCRETA\/percreta: impact of diagnostic methods and management on maternal morbidity. Acta Obstet Gynecol Scand 2013 Apr;92(4):476\u201382.","DOI":"10.1111\/aogs.12078"},{"key":"7682_CR70","doi-asserted-by":"crossref","unstructured":"Pinton A, Deneux-Tharaux C, Seco A, Sentilhes L, Kayem G; PACCRETA Study Group. Incidence and risk factors for severe postpartum haemorrhage in women with anterior low-lying or praevia placenta and prior caesarean: Prospective population-based study. BJOG 2023;130:1653\u20131661.","DOI":"10.1111\/1471-0528.17554"},{"key":"7682_CR71","unstructured":"Blondel B, Coulm B, Bonnet C; French National Perinatal Surveys 2016.\u00a0[cited 2025 Feb 26]. Available from: https:\/\/enp.inserm.fr\/wp-content\/uploads\/2020\/12\/Rapport2016_Anglais.pdf."},{"key":"7682_CR72","unstructured":"Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, et al on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. BJOG 2016;124:e106\u2013e149."},{"key":"7682_CR73","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0884","volume":"156","author":"I Taeuber","year":"2021","unstructured":"Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, et al. Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. JAMA Surg. 2021;156: e210884.","journal-title":"JAMA Surg"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07682-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:30:13Z","timestamp":1748597413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07682-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7682"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07682-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was designed and is implemented in accordance with the Declaration of Helsinki\u2019s principles on studies involving human subjects.TRAAPREVIA trial was approved.- by the Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM) (national agency for drug safety), March 12, 2020.- by the following Approval Committee: Comit\u00e9 de Protection des Personnes (CPP South East III) (Committee for protection of persons involved in biomedical research), March 5, 2020.\nInformed written consent will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Lo\u00efc Sentilhes reports receiving lecture fees from Norgine, and lecture and consulting fees from Ferring Pharmaceuticals, GlaxoSmithKline, Pfizer, Organon and Bayer. The other authors did not report any potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"635"}}